Plasma pentosidine levels measured by a newly developed method using ELISA in patients with chronic renal failure

被引:59
作者
Sanaka, T [1 ]
Funaki, T [1 ]
Tanaka, T [1 ]
Hoshi, S [1 ]
Niwayama, J [1 ]
Taitoh, T [1 ]
Nishimura, H [1 ]
Higuchi, C [1 ]
机构
[1] Tokyo Womens Med Univ, Daini Hosp Med Ctr, Dept Nephrol & Blood Purificat, Arakawa Ku, Tokyo 1168567, Japan
来源
NEPHRON | 2002年 / 91卷 / 01期
关键词
pentosidine; enzyme-linked immunosorbent assay; phosphatidylcholine hydroperoxide; chronic renal failure;
D O I
10.1159/000057606
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The plasma pentosidine levels in patients with renal disease were measured by a simple method which was established for plasma and urinary pentosidine determinations. The method, which can be completed within a few hours, involves pretreating plasma with proteolytic enzyme (pronase) and measuring the concentration of pentosidine in the sample by ELISA using antipentosidine antibodies. The prepared antibodies showed no cross-reaction with the raw materials for pentosidine synthesis or with compounds having similar structures. SIDS-PAGE indicated that the antibodies had a high purity. The reaction of the antibodies and keyhole limpet hemocyanin-pentosidine in the competitive ELISA system was inhibited by free pentosidine. Excellent standard curves for pentosidine determination were obtained. In actual measurements of clinical samples from patients, a good correlation (r=0.9356) was obtained between the values measured by ELISA and HPLC. The plasma pentosidine level in patients with renal disease correlated significantly with plasma creatinine, urea nitrogen, beta(2)-Microglobulin, and creatinine clearance, indicating its usefulness in evaluating the severity of renal disease. A significant elevation in plasma pentosidine levels was observed in mild renal dysfunction, whereas no significant increases in creatinine and urea nitrogen levels were detected, suggesting that the plasma pentosidine level is useful in the early diagnosis of beginning renal failure. In patients with chronic renal failure, no difference in plasma pentosidine levels was observed between diabetic nephropathy and chronic glomerulonephritis, while a significant correlation was observed with phosphatidylcholine hydroperoxide, suggesting the possibility that the plasma pentosidine level reflects injury due to oxidation. From these results, the quantitative measurement method developed by us is judged to be a superior innovation for measuring pentosidine in body fluids. The plasma pentosidine level may be useful for the early diagnosis of mild renal failure and to estimate the degree of the severity of renal diseases. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 50 条
  • [41] Anxiety Levels and Coping Styles of Chronic Renal Failure Patients: The Hacettepe University Nephrology Department Example
    Erbay, Ercument
    Zengin, Oguzhan
    Yildirim, Bugra
    Yildirim, Tolga
    Abudalal, Ayman
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2016, 25 (01): : 95 - 99
  • [42] Oral Adsorbent AST-120 Decreases Serum Levels of AGEs in Patients with Chronic Renal Failure
    Seiji Ueda
    Sho-ichi Yamagishi
    Masayoshi Takeuchi
    Keisuke Kohno
    Ryo Shibata
    Yuriko Matsumoto
    Utako Kaneyuki
    Toshiko Fujimura
    Ayako Hayashida
    Seiya Okuda
    Molecular Medicine, 2006, 12 : 180 - 184
  • [43] Circulating levels of osteoprotegerin and receptor activator of NF-κB ligand in patients with chronic renal failure
    Shaarawy, Mohamed
    Fathy, Shadia A.
    Mehany, Nagy L.
    Hindy, Odette W.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (11) : 1498 - 1503
  • [44] Serum levels of 1-84 and 7-84 parathyroid hormone in predialysis patients with chronic renal failure measured by the intact and bio-PTH assay
    Tsuchida, T
    Ishimura, E
    Hirowatari, K
    Matsumoto, N
    Imanishi, Y
    Jono, S
    Miki, T
    Inaba, M
    Nishizawa, Y
    NEPHRON CLINICAL PRACTICE, 2006, 102 (3-4): : C108 - C114
  • [45] IS PERITONEAL-DIALYSIS AN ADEQUATE METHOD FOR TREATMENT OF ELDERLY PATIENTS WITH CHRONIC-RENAL-FAILURE
    MICHEL, C
    ALBERT, C
    VIRON, B
    MIGNON, F
    NEPHROLOGIE, 1990, 11 (05): : 331 - 335
  • [46] Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure
    Bronisław A. Zachara
    Dominika Koterska
    Jacek Manitius
    Leszek Sadowski
    Andrzej Dziedziczko
    Anna Salak
    Wojciech Wasowicz
    Biological Trace Element Research, 2004, 97 : 15 - 30
  • [47] Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure
    Pawlak, Krystyna
    Myshwiec, Michal
    Pawlak, Dariusz
    CYTOKINE, 2008, 43 (01) : 98 - 101
  • [48] Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure
    Zachara, BA
    Koterska, D
    Manitius, J
    Sadowski, L
    Dziedziczko, A
    Salak, A
    Wasowicz, W
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2004, 97 (01) : 15 - 30
  • [49] Increased plasma concentrations of lipoprotein(a) for every phenotype of apolipoprotein(a) in patients with chronic renal failure treated by hemodialysis
    Gazzaruso, C
    Bonetti, G
    Garzaniti, A
    Pini, G
    Ragazzoni, A
    Bianchi, C
    Jucci, A
    Buscaglia, P
    Geroldi, D
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1996, 6 (04) : 203 - 210
  • [50] Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure
    Ewa M. Slominska
    Ryszard T. Smolenski
    Marek Szolkiewicz
    Neil Leaver
    Boleslaw Rutkowski
    H. Anne Simmonds
    Julian Swierczynski
    Molecular and Cellular Biochemistry, 2002, 231 : 83 - 88